We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+8.79%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.67B
AUM Growth
+$449M
Cap. Flow
+$100M
Cap. Flow %
1.77%
Top 10 Hldgs %
21.33%
Holding
617
New
29
Increased
183
Reduced
116
Closed
41

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$44.1M
2
ACGL icon
Arch Capital
ACGL
+$36.2M
3
XYL icon
Xylem
XYL
+$35.6M
4
AME icon
Ametek
AME
+$12M
5
GWW icon
W.W. Grainger
GWW
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Healthcare 19.27%
3 Consumer Discretionary 10.8%
4 Industrials 9.16%
5 Financials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SANA icon
476
Sana Biotechnology
SANA
$977M
$236K ﹤0.01%
40,000
CRVL icon
477
CorVel
CRVL
$3.19B
$233K ﹤0.01%
3,600
SWKS icon
478
Skyworks Solutions
SWKS
$10.1B
$232K ﹤0.01%
2,098
-478
-19% -$50.4K
BNY
479
Bank of New York Mellon
BNY
$108B
$231K ﹤0.01%
+5,181
New +$222K
GLW icon
480
Corning
GLW
$135B
$228K ﹤0.01%
+6,514
New +$214K
KROS icon
481
Keros Therapeutics
KROS
$198M
$227K ﹤0.01%
5,700
INBX
482
DELISTED
Inhibrx, Inc. Common Stock
INBX
$224K ﹤0.01%
8,700
CINF icon
483
Cincinnati Financial
CINF
$27.3B
$222K ﹤0.01%
2,300
RDN icon
484
Radian Group
RDN
$5.21B
$221K ﹤0.01%
8,800
WCN
485
Waste Connections
WCN
$41.5B
$218K ﹤0.01%
+1,554
New +$217K
VERV
486
DELISTED
Verve Therapeutics
VERV
$212K ﹤0.01%
11,300
CHGG icon
487
Chegg
CHGG
$115M
$210K ﹤0.01%
23,808
ESNT icon
488
Essent Group
ESNT
$6.13B
$205K ﹤0.01%
4,400
HYG icon
489
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$205K ﹤0.01%
2,730
MTG icon
490
MGIC Investment
MTG
$6.27B
$200K ﹤0.01%
12,800
UNM icon
491
Unum
UNM
$14.1B
$195K ﹤0.01%
4,100
FAF icon
492
First American
FAF
$7.66B
$182K ﹤0.01%
3,200
BILI icon
493
Bilibili
BILI
$7.78B
$179K ﹤0.01%
12,000
PVH icon
494
PVH
PVH
$4.01B
$179K ﹤0.01%
2,137
-143
-6% -$12.1K
SIGI icon
495
Selective Insurance
SIGI
$5.76B
$175K ﹤0.01%
1,800
LYEL icon
496
Lyell Immunopharma
LYEL
$330M
$169K ﹤0.01%
2,700
BRK.B icon
497
Berkshire Hathaway Class B
BRK.B
$1.12T
$169K ﹤0.01%
495
+50
+11% +$16.3K
CGNX icon
498
Cognex
CGNX
$11.8B
$168K ﹤0.01%
3,000
TDOC icon
499
Teladoc Health
TDOC
$1.26B
$168K ﹤0.01%
6,649
TEAM icon
500
Atlassian
TEAM
$28.8B
$168K ﹤0.01%
1,000

Similar funds

Erste Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Erste Asset Management held 617 positions worth $5.67B, up 8.6% from $5.22B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Erste Asset Management's Q2 2023 filing shows 29 new, 183 increased, 116 reduced and 41 closed positions. Its largest new stake was UiPath: 660,000 shares worth $11M. The largest sale was Evoqua Water Technologies Corp. Common Stock, an estimated $37.3M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q2 2023 buy was UiPath: 660,000 shares worth $11M.
  • Erste Asset Management added most to AstraZeneca in Q2 2023, an estimated $44.1M increase.
  • Erste Asset Management's biggest Q2 2023 reduction was Progressive, cutting an estimated $31.7M.
  • Erste Asset Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $37.3M.
  • Erste Asset Management's ten largest holdings make up 21% of its $5.67B portfolio in Q2 2023.
  • Erste Asset Management opened 29 new positions and closed 41 in Q2 2023.
  • Erste Asset Management's portfolio value rose 8.6% quarter-over-quarter to $5.67B.

Based on Erste Asset Management's 13F filing for Q2 2023, filed 26 Nov 2024.